These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35350019)

  • 21. Laparoscopic Ovarian Drilling Reduces Testosterone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio and Improves Clinical Outcome in Women with Polycystic Ovary Syndrome.
    Sinha P; Chitra T; Papa D; Nandeesha H
    J Hum Reprod Sci; 2019; 12(3):224-228. PubMed ID: 31576080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatible cut-off values for luteinizing hormone and the luteinizing hormone/follicle-stimulating hormone ratio in diagnostic criteria of the Japan Society of Obstetrics and Gynecology for polycystic ovary syndrome.
    Yanagihara R; Matsuzaki T; Aoki H; Tamura K; Nagashima M; Minato S; Kamada S; Yamamoto Y; Irahara M; Iwasa T
    J Obstet Gynaecol Res; 2023 Jan; 49(1):253-264. PubMed ID: 36307043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
    Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
    Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study on evaluation and determination of the prevalence of Polycystic Ovarian Syndrome (PCOS) associated gene markers in the South Indian population.
    Ramanathan B; Murugan J; Velayutham K
    Indian J Endocrinol Metab; 2021; 25(6):551-558. PubMed ID: 35355907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome.
    Mansour A; Hashemi Taheri AP; Moradi B; Mohajeri-Tehrani MR; Qorbani M; Ghorbani Pashakolaee S; Sanginabadi M; Sajjadi-Jazi SM
    BMC Endocr Disord; 2022 Dec; 22(1):298. PubMed ID: 36456925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India.
    Nath CK; Barman B; Das A; Rajkhowa P; Baruah P; Baruah M; Baruah A
    J Family Med Prim Care; 2019 Jan; 8(1):256-260. PubMed ID: 30911516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Angiotensin-Converting Enzyme gene polymorphism in Pakistani women with the atypical steroidogenesis in Polycystic ovarian syndrome: A case-control study.
    Nazeer K; Munawar Lone N; Sadique S; Sultan S; Zia Eupash A; Riaz S
    Saudi J Biol Sci; 2021 Jun; 28(6):3483-3489. PubMed ID: 34121888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
    Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
    Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
    Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of gonadotropins to pituitary stimulation with luteinizing hormone releasing hormone is a more specific than sensitive parameter for the polycystic ovary syndrome.
    Steck T; Wernze H; Albert PJ
    Gynecol Endocrinol; 1991 Dec; 5(4):235-47. PubMed ID: 1796746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.
    Thangavelu M; Godla UR; Paul Solomon FD; Maddaly R
    J Genet; 2017 Mar; 96(1):87-96. PubMed ID: 28360393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.
    Pembe AB; Abeid MS
    Tanzan J Health Res; 2009 Oct; 11(4):175-80. PubMed ID: 20734696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of luteinizing hormone hypersecretion in different phases of the menstrual cycle in polycystic ovary syndrome.
    Iwasa T; Matsuzaki T; Murakami M; Shimizu F; Kuwahara A; Yasui T; Irahara M
    J Obstet Gynaecol Res; 2009 Jun; 35(3):514-9. PubMed ID: 19527392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M; Azziz R; Beires J; Pignatelli D
    Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of hormonal and anthropometric parameters in polycystic ovarian syndrome.
    Kambale T; Sawaimul KD; Prakash S
    Ann Afr Med; 2023; 22(1):112-116. PubMed ID: 36695232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.